新冠疫情以来重症监护室中严重肢体缺血的对比分析
该回顾性分析比较同一机构2020年新冠疫情期间与2019年疫情前ICU患者,主要结局为ICU内新发肢体坏疽、死亡和大截肢。2020年249例新冠阳性患者中发生12例坏疽,2019年1846例ICU入院中随机抽取249例无坏疽;新冠组坏疽患者仅16.7%既往有动脉疾病,多变量logistic回归显示新冠感染与坏疽风险增加18.23倍相关。
要点
- 2020年ICU新冠患者249例中发生12例坏疽,2019年随机抽取的249例ICU患者中无坏疽。
- 新冠组坏疽患者仅16.7%既往已知动脉疾病,吸烟可能性为四倍(P=0.004)。
- 多变量logistic回归显示新冠感染与坏疽风险增加18.23倍相关。
核心结论
- 新冠感染与ICU内肢体坏疽风险增加18.23倍相关,且坏疽患者多无基础动脉疾病。
- 作者强调临床医生应认识无基础动脉疾病且合并症少者中的新冠诱导严重肢体缺血。
- 作者认为需尽快开展更多研究以预防截肢和新冠凝血病。
研究设计与样本
- 单机构回顾性分析,比较2020年新冠疫情期间与2019年疫情前两个患者子集。
- 2020年ICU收治249例新冠阳性患者;2019年ICU入院1846例,随机抽取249例进行病历回顾。
- 收集两组人口学数据和用药史,主要结局为ICU内新发肢体坏疽、死亡和大截肢。
主要发现
- ICU内发生13例坏疽,其中12例发生在2020年。
- 住院死亡率:2019年非新冠患者11.6% vs 2021年41.4%(P < 0.001)。
- 新冠组坏疽患者仅16.7%既往已知动脉疾病,吸烟可能性为四倍(P = 0.004)。
- 合并坏疽组住院时间更长、输血需求更高、需大截肢和血运重建。
- 多变量logistic回归显示新冠感染与坏疽风险增加18.23倍相关。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Emerging data and case reports have found coagulation abnormalities and thrombosis as sequelae of infection with SARS-CoV-2 (COVID-19). Case reports have reported thrombotic complications caused by COVID-19-related coagulopathy leading to limb loss. Alarmingly, many of these patients had no underlying vascular disease prior to being infected with COVID-19. Many of these case reports discuss patients developing gangrene in the intensive care unit (ICU). Our study compares the incidence of gangrene in the ICU in COVID-19 patients to baseline inpatient levels prior to the pandemic. METHODS: This retrospective analysis investigates two subsets of patients from a single institution. The first was from 2020 during the COVID-19 pandemic; the second subset was from 2019 before the pandemic. Demographic data and medication history were ascertained for both groups. Primary outcomes measures included extremity gangrene that developed in the ICU, mortality, and major amputation. RESULTS: There were 249 COVID-19 positive patients admitted to the ICU in 2020. In 2019, 1,846 admissions to the ICU took place, of which 249 patients were randomized to chart review. There were 13 cases of gangrene that developed in the ICU, 12 of which took place in 2020. In-hospital mortality was 11.6% in nonCOVID-19 patients in 2019 vs. 41.4% in 2021 (P < 0.001). Only 16.7% of the COVID-19 gangrene patients had previously known arterial disease. Also, patients in the COVID-19 group with gangrene were four times more likely to be smokers (P = 0.004). When the data were stratified to compare between gangrene development and no gangrene development, the combined total gangrene group had longer hospital stays, higher need for blood transfusions, required major amputations, and revascularization. A multivariate logistic regression from the total study similarly demonstrated that COVID-19 infection is associated with an 18.23 times increased risk of gangrene. CONCLUSIONS: COVID-19 has resulted in an incomprehensible societal impact that will linger for years to come. The last 2 years have reinforced that COVID-19 will be a part of our clinical practice indefinitely. This study emphasizes the importance of clinician awareness of COVID-19 induced critical limb ischemia in those without underlying arterial disease and few medical comorbidities. More research efforts toward preventing limb loss and COVID-19 coagulopathy must be performed expeditiously to achieve a better understanding.
引用
- Malkoc A, GnanaDev R, Botea L, et al. A Comparative Analysis of Critical Limb Ischemia in the Intensive Care Unit since the COVID-19 Pandemic. Ann Vasc Surg. 2022. PMID: 36481674. doi:10.1016/j.avsg.2022.11.001
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。